The National Rosacea Society (NRS) has awarded funding for three new studies, in addition to continuing support for three ongoing studies.
Rosacea Review: Fall 2017
When the National Rosacea Society was founded 25 years ago, very few Americans were aware of this chronic skin disorder, even though it’s now estimated to affect more than 16 million in the U.S. alone. Here is a timeline that traces the recorded history of rosacea in art, literature and medical texts up to the present:
Results from a new National Rosacea Society survey found that most rosacea patients practice a thorough and gentle facial hygiene routine that involves washing twice daily with warm water and a non-soap cleanser, and blotting their face dry with a towel.
Sixty-five percent of the 719 rosacea patients surveyed said they wash their face twice daily in the morning and evening. Sixteen percent said they wash their face once daily in the morning, while 14 percent wash their face once daily in the evening. Only around 3 percent of patients washed their face less often than once daily.
The ways in which disruptions and imbalances in the ecosystem of bacteria, Demodex mites and other microorganisms on the skin, known collectively as the skin microbiota, may be involved in the development of rosacea were discussed at the summer meeting of the American Academy of Dermatology in New York.
While the treatment may be the same as in lighter skin, diagnosing rosacea in patients with dark skin types may be more challenging, according to Dr. Andrew Alexis, associate professor of dermatology at the Icahn School of Medicine at Mount Sinai, during a session at the summer meeting of the American Academy of Dermatology in New York.
While avoidance of trigger factors, gentle cleansing and a variety of medical therapies are among today’s options for controlling ocular rosacea, continuing research on its pathophysiology is uncovering potential avenues for the development of important new advances in its treatment, according to Dr. Edward Wladis, associate professor and vice-chairman of ophthalmology at Albany Medical College, in a recent article in the medical journal Survey of Ophthalmology.1
Published by the National Rosacea Society.
Editor: Dr. Lynn Drake, Department of Dermatology, Harvard Medical School.
Managing Editor: Andrew Huff.
Rosacea Review is a newsletter published by the National Rosacea Society for people with rosacea. The newsletter covers information pertaining to the disease and its control, including news on research, results of patient surveys, success stories, lifestyle and environmental factors, and tips on managing its signs and symptoms. To receive Rosacea Review by mail, please join the NRS. You can also sign up to receive the newsletter by email.
196 James St.
Barrington, IL 60010
The National Rosacea Society is a 501(c)(3) nonprofit organization whose mission is to improve the lives of people with rosacea by raising awareness, providing public health information and supporting medical research on this widespread but little-known disorder. The information the Society provides should not be considered medical advice, nor is it intended to replace
consultation with a qualified physician. The Society does not evaluate, endorse or recommend any particular medications, products, equipment or treatments. Rosacea may vary substantially from one patient to another, and treatment must be tailored by a physician for each individual case. For more information, visit About Us.